Hematopoietic SCT in Europe: data and trends in 2011

In all, 651 from 680 centers in 48 countries reported 35 660 hematopoietic SCT (HSCT) in 32 075 patients (13 470 allogeneic (42%), 18 605 autologous (58%)) to the 2011 survey. Main indications were: leukemias; 10 113 (32%; 94% allogeneic); lymphoid neoplasias; non-Hodgkin’s lymphoma, Hodgkin’s lymph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Passweg, Jakob R. (VerfasserIn) , Baldomero, H. (VerfasserIn) , Bregni, M. (VerfasserIn) , Cesaro, S. (VerfasserIn) , Dreger, Peter (VerfasserIn) , Duarte, R. F. (VerfasserIn) , Falkenburg, J. H. F. (VerfasserIn) , Kröger, N. (VerfasserIn) , Farge-Bancel, D. (VerfasserIn) , Bobby Gaspar, H. (VerfasserIn) , Marsh, J. (VerfasserIn) , Mohty, M. (VerfasserIn) , Peters, C. (VerfasserIn) , Sureda, A. (VerfasserIn) , Velardi, A. (VerfasserIn) , Ruiz de Elvira, C. (VerfasserIn) , Madrigal, A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 April 2013
In: Bone marrow transplantation
Year: 2013, Jahrgang: 48, Heft: 9, Pages: 1161-1167
ISSN:1476-5365
DOI:10.1038/bmt.2013.51
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bmt.2013.51
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bmt201351
Volltext
Verfasserangaben:J.R. Passweg, H. Baldomero, M. Bregni, S. Cesaro, P. Dreger, R. F. Duarte, J.H.F. Falkenburg, N. Kröger, D. Farge-Bancel, H. Bobby Gaspar, J. Marsh, M. Mohty, C. Peters, A. Sureda, A. Velardi, C. Ruiz de Elvira and A. Madrigal

MARC

LEADER 00000caa a2200000 c 4500
001 178258269X
003 DE-627
005 20220820095825.0
007 cr uuu---uuuuu
008 211220s2013 xx |||||o 00| ||eng c
024 7 |a 10.1038/bmt.2013.51  |2 doi 
035 |a (DE-627)178258269X 
035 |a (DE-599)KXP178258269X 
035 |a (OCoLC)1341436520 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Passweg, Jakob R.  |d 1959-  |e VerfasserIn  |0 (DE-588)1077588011  |0 (DE-627)837268265  |0 (DE-576)446392251  |4 aut 
245 1 0 |a Hematopoietic SCT in Europe  |b data and trends in 2011  |c J.R. Passweg, H. Baldomero, M. Bregni, S. Cesaro, P. Dreger, R. F. Duarte, J.H.F. Falkenburg, N. Kröger, D. Farge-Bancel, H. Bobby Gaspar, J. Marsh, M. Mohty, C. Peters, A. Sureda, A. Velardi, C. Ruiz de Elvira and A. Madrigal 
264 1 |c 15 April 2013 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.12.2021 
520 |a In all, 651 from 680 centers in 48 countries reported 35 660 hematopoietic SCT (HSCT) in 32 075 patients (13 470 allogeneic (42%), 18 605 autologous (58%)) to the 2011 survey. Main indications were: leukemias; 10 113 (32%; 94% allogeneic); lymphoid neoplasias; non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, plasma cell disorders; 18 433 (57%; 12% allogeneic); solid tumours; 1573 (5%; 5% allogeneic); and non-malignant disorders; 1830 (6%; 92% allogeneic). There were more unrelated donors than HLA identical sibling donors (54% versus 39%); proportion of peripheral blood as stem cell source was 99% for autologous and 73% for allogeneic HSCT. Cord blood was only used in allogeneic transplants (6% of total). In the past 10 years, the overall number of transplants has increased by 53%. Allogeneic HSCT have doubled (from 7272 to 14 549) while, autologous have increased by 32% and continue to increase by about 1100 HSCT per year since 2001. In the past 2 years, an increase of >2000 HSCT per year was seen. Transplant activity is shown by team size. For allogeneic HSCT, we show use of reduced-intensity conditioning versus myeloablative conditioning across Europe and use of post-transplant donor lymphocyte infusions with considerable variation across different countries. 
650 4 |a Bone marrow transplantation 
650 4 |a Therapeutics 
700 1 |a Baldomero, H.  |e VerfasserIn  |4 aut 
700 1 |a Bregni, M.  |e VerfasserIn  |4 aut 
700 1 |a Cesaro, S.  |e VerfasserIn  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Duarte, R. F.  |e VerfasserIn  |4 aut 
700 1 |a Falkenburg, J. H. F.  |e VerfasserIn  |4 aut 
700 1 |a Kröger, N.  |e VerfasserIn  |4 aut 
700 1 |a Farge-Bancel, D.  |e VerfasserIn  |4 aut 
700 1 |a Bobby Gaspar, H.  |e VerfasserIn  |4 aut 
700 1 |a Marsh, J.  |e VerfasserIn  |4 aut 
700 1 |a Mohty, M.  |e VerfasserIn  |4 aut 
700 1 |a Peters, C.  |e VerfasserIn  |4 aut 
700 1 |a Sureda, A.  |e VerfasserIn  |4 aut 
700 1 |a Velardi, A.  |e VerfasserIn  |4 aut 
700 1 |a Ruiz de Elvira, C.  |e VerfasserIn  |4 aut 
700 1 |a Madrigal, A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 48(2013), 9, Seite 1161-1167  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Hematopoietic SCT in Europe data and trends in 2011 
773 1 8 |g volume:48  |g year:2013  |g number:9  |g pages:1161-1167  |g extent:7  |a Hematopoietic SCT in Europe data and trends in 2011 
856 4 0 |u https://doi.org/10.1038/bmt.2013.51  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bmt201351  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211220 
993 |a Article 
994 |a 2013 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 5 
999 |a KXP-PPN178258269X  |e 4022816333 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"pages":"1161-1167","extent":"7","year":"2013","volume":"48","issue":"9","text":"48(2013), 9, Seite 1161-1167"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke ; London","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 17.01.25"],"disp":"Hematopoietic SCT in Europe data and trends in 2011Bone marrow transplantation","title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"id":{"issn":["1476-5365"],"zdb":["2004030-1"],"eki":["320433366"]},"pubHistory":["Nachgewiesen 19.1997 -"],"recId":"320433366"}],"name":{"displayForm":["J.R. Passweg, H. Baldomero, M. Bregni, S. Cesaro, P. Dreger, R. F. Duarte, J.H.F. Falkenburg, N. Kröger, D. Farge-Bancel, H. Bobby Gaspar, J. Marsh, M. Mohty, C. Peters, A. Sureda, A. Velardi, C. Ruiz de Elvira and A. Madrigal"]},"person":[{"roleDisplay":"VerfasserIn","family":"Passweg","role":"aut","display":"Passweg, Jakob R.","given":"Jakob R."},{"display":"Baldomero, H.","role":"aut","given":"H.","roleDisplay":"VerfasserIn","family":"Baldomero"},{"roleDisplay":"VerfasserIn","family":"Bregni","given":"M.","display":"Bregni, M.","role":"aut"},{"given":"S.","role":"aut","display":"Cesaro, S.","roleDisplay":"VerfasserIn","family":"Cesaro"},{"given":"Peter","display":"Dreger, Peter","role":"aut","roleDisplay":"VerfasserIn","family":"Dreger"},{"family":"Duarte","roleDisplay":"VerfasserIn","given":"R. F.","role":"aut","display":"Duarte, R. F."},{"given":"J. H. F.","display":"Falkenburg, J. H. F.","role":"aut","family":"Falkenburg","roleDisplay":"VerfasserIn"},{"display":"Kröger, N.","role":"aut","given":"N.","roleDisplay":"VerfasserIn","family":"Kröger"},{"role":"aut","display":"Farge-Bancel, D.","given":"D.","roleDisplay":"VerfasserIn","family":"Farge-Bancel"},{"role":"aut","display":"Bobby Gaspar, H.","given":"H.","roleDisplay":"VerfasserIn","family":"Bobby Gaspar"},{"given":"J.","display":"Marsh, J.","role":"aut","roleDisplay":"VerfasserIn","family":"Marsh"},{"given":"M.","role":"aut","display":"Mohty, M.","family":"Mohty","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Peters","role":"aut","display":"Peters, C.","given":"C."},{"display":"Sureda, A.","role":"aut","given":"A.","roleDisplay":"VerfasserIn","family":"Sureda"},{"family":"Velardi","roleDisplay":"VerfasserIn","role":"aut","display":"Velardi, A.","given":"A."},{"family":"Ruiz de Elvira","roleDisplay":"VerfasserIn","given":"C.","display":"Ruiz de Elvira, C.","role":"aut"},{"family":"Madrigal","roleDisplay":"VerfasserIn","given":"A.","display":"Madrigal, A.","role":"aut"}],"physDesc":[{"extent":"7 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"15 April 2013","dateIssuedKey":"2013"}],"language":["eng"],"note":["Gesehen am 20.12.2021"],"recId":"178258269X","id":{"doi":["10.1038/bmt.2013.51"],"eki":["178258269X"]},"title":[{"subtitle":"data and trends in 2011","title":"Hematopoietic SCT in Europe","title_sort":"Hematopoietic SCT in Europe"}]} 
SRT |a PASSWEGJAKHEMATOPOIE1520